Among these enzymes, mucosal NOXs and dual oxidase 2 (DUOX2) have been reported as novel risk factors for IBD52,53, further demonstrating that an imbalance in redox homeostasis contributes to the pathogenesis of IBD. This evidence concerns the gene DUOX2 and inflammatory bowel disease.